Company / Revenue per Share
Tango Therapeutics, Inc. Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.58
FY2025
5-year range
$0.19 / $0.58
FY2021-FY2025
Trend
+40.7%
vs FY2024
Sector context
#115 of 154
Health Care
What the data says
Tango Therapeutics, Inc.'s revenue per share of $0.58 is lower than 75% of companies in the Health Care sector (FY2025). Revenue per Share returned to growth in FY2025 after 2 years of decline, reaching $0.58.
Based on SEC 10-K filings.
0.58 in FY2025 with a 5-year CAGR of +19.3%.
Improved from $0.41 to $0.58 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +11.0%
- 5-Year CAGR
- +19.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 154This company $0.58 Sector average $15.09
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 40.7% year-over-year.
- Ranks #115 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.58 | +40.7% |
| FY2024 | $0.41 | -0.6% |
| FY2023 | $0.41 | -2.2% |
| FY2022 | $0.42 | +123.3% |
| FY2021 | $0.19 | -20.9% |
| FY2020 | $0.24 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026